We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Northw.Bio Di | LSE:NWBT | London | Ordinary Share | COM SHS USD0.001 (DI) |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 15.00 | - | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
| Date | Subject | Author | Discuss |
|---|---|---|---|
| 02/9/2020 22:01 | Great day. Patience paid off. | duxy786 | |
| 10/10/2007 14:02 | NWBT have developed the world's first therapeutic vaccine for Brain Cancer, DCVax(R)-Brain, which is commercially available to patients in Switzerland. Clinical trial data has shown that the vaccine delays disease recurrence by nearly 3-fold, from 6.9 months to 18.1 months for newly diagnosed patients, and also extends these patients' survival from 14.6 months to more than 33 months. | kozel | |
| 10/10/2007 13:16 | Northwest Biotherapeutics, Inc. is a development stage biotechnology company focused on discovering, developing and commercialising immunotherapy products that generate and enhance immune system responses to treat cancer. Website: | kozel |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
